This activity is a recording of a live webinar, if you claimed credit for the live activity, you should not claim credit for this activity.
Activity Overview
Join experts for a webinar exploring the evolving landscape of diabetes management in the emergency department (ED). Despite updates to clinical guidelines, emerging therapies, and new medication classes, diabetic ketoacidosis (DKA) remains a leading cause of EDvisits. As hospitals face increased patient volumes and prolonged ED boarding, this session will highlight innovative DKA treatment strategies that may allow for safe outpatient management or reduced inpatient stays—helping to optimize bed availability and make the most of limited healthcare resources.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
This activity was planned to meet the educational needs of pharmacists who practice in the emergency department and encounter patients with suspected diabetic ketoacidosis.
Julianne Yeary, PharmD, BCCCP, BCEMP Clinical Pharmacy Specialist – Emergency Medicine Charles F. Knight Emergency and Trauma Center, Barnes-Jewish Hospital St Louis, MO
Brian Gilbert, PharmD, MBA, FCCM, FNCS, FCCP, FKCHP Emergency Medicine Clinical Pharmacy Specialist Department of Pharmacy, Wesley Medical Center Wichita, KS
Francisco Ibarra Jr, PharmD, BCCCP Emergency Medicine Clinical Pharmacist Community Regional Medical Center Fresno, CA
Jennifer Esch, PharmD, MBA, BCPS Clinical Pharmacist Specialist Aurora BayCare Medical Center Green Bay, WI
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.
